SEC Form 4 · accession 0001179110-16-018452

GILEAD SCIENCES, INC. · GILD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP Commercial Ops

Period of report

Feb 1, 2016

Accepted (ET)

Feb 3, 2016 · 5:42 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000882095

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 1, 2016	M	182	$24.905	A	48,965	D
Common Stock	Feb 1, 2016	M	1,818	$40.56	A	50,783	D
Common Stock	Feb 1, 2016	S	2,000	$82.32	D	48,783	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$24.905	Feb 1, 2016	M	182	D	—	Jul 29, 2019	Common Stock	182	38,641	D
Non-Qualified Stock Option (right to buy)^F3	$40.56	Feb 1, 2016	M	1,818	D	—	Feb 1, 2023	Common Stock	1,818	8,437	D
Non-Qualified Stock Option (right to buy)^F3	$84.05	Feb 1, 2016	A	42,880	A	—	Feb 1, 2026	Common Stock	42,880	42,880	D

F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.